{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:49:48Z","timestamp":1790999388059,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Direcci\u00f3 General d\u2019Universitat, Investigaci\u00f3 i Ci\u00e8ncia, GVA","award":["AICO\/2018\/090"],"award-info":[{"award-number":["AICO\/2018\/090"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00665"],"award-info":[{"award-number":["PI15\/00665"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19-01359"],"award-info":[{"award-number":["PI19-01359"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministerio de Econom\u00eda y Competitividad, through the \u201cSevero Ochoa\u201d Programme for Centres of Excellence in R&D","award":["SEV-2017-0723"],"award-info":[{"award-number":["SEV-2017-0723"]}]},{"DOI":"10.13039\/501100015496","name":"CIBERNED","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The amyloid precursor protein (APP) is a transmembrane glycoprotein that undergoes alternative proteolytic processing. Its processing through the amyloidogenic pathway originates a large sAPP\u03b2 ectodomain fragment and the \u03b2-amyloid peptide, while non-amyloidogenic processing generates sAPP\u03b1 and shorter non-fibrillar fragments. Hence, measuring sAPP\u03b1 and sAPP\u03b2 has been proposed as a means to identify imbalances between the amyloidogenic\/non-amyloidogenic pathways in the brain of Alzheimer\u2019s disease (AD) patients. However, to date, no consistent changes in these proteolytic fragments have been identified in either the brain or cerebrospinal fluid of AD individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In frontal cortex homogenates from AD patients (<jats:italic>n<\/jats:italic>\u2009=\u20097) and non-demented controls (NDC; <jats:italic>n<\/jats:italic>\u2009=\u20097), the expression of total APP mRNA and that of the APP isoforms generated by alternative splicing, APP695 and APP containing the Kunitz protease inhibitor (KPI), was analyzed by <jats:italic>q<\/jats:italic>RT-PCR using TaqMan and SYBR Green probes. The balance between the amyloidogenic\/non-amyloidogenic pathways was examined in western blots estimating the sAPP\u03b1 and sAPP\u03b2 fragments and their membrane-tethered C-terminal fragments CTF\u03b1 and CTF\u03b2. CHO-PS70 cells, stably over-expressing wild-type human APP, served to evaluate whether A\u03b242 peptide treatment results in altered APP glycosylation. We determined the glycosylation pattern of sAPP\u03b1 and sAPP\u03b2 in brain extracts and CHO-PS70 culture media by lectin-binding assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the cortex of AD patients, we detected an increase in total APP mRNA relative to the controls, due to an increase in both the APP695 and APP-KPI variants. However, the sAPP\u03b1 or sAPP\u03b2 protein levels remained unchanged, as did those of CTF\u03b1 and CTF\u03b2. We studied the glycosylation of the brain sAPP\u03b1 and sAPP\u03b2 using lectins and pan-specific antibodies to discriminate between the fragments originated from neuronal APP695 and glial\/KPI variants. Lectin binding identified differences in the glycosylation of sAPP\u03b2 species derived from the APP695 and APP-KPI variants, probably reflecting their distinct cellular origin. Moreover, the lectin-binding pattern differed in the sAPP\u03b1 and sAPP\u03b2 originated from all the variants. Finally, when the lectin-binding pattern was compared between AD and NDC groups, significant differences were evident in sAPP\u03b1 glycosylation. Lectin binding of the soluble sAPP\u03b1 and sAPP\u03b2 from CHO-PS70 cells were also altered in cells treated with the A\u03b2 peptide.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our analysis of the lectin binding to sAPP\u03b1 and sAPP\u03b2 suggests that glycosylation dictates the proteolytic pathway for APP processing. Differences between the demented and controls indicate that changes in glycosylation may influence the generation of the different APP fragments and, consequently, the pathological progression of AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-020-00664-9","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T17:04:10Z","timestamp":1597251850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Claudia P.","family":"Boix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Lopez-Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Cuchillo-Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-320X","authenticated-orcid":false,"given":"Javier","family":"S\u00e1ez-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"issue":"1","key":"664_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jb\/mvw056","volume":"161","author":"K Akasaka-Manya","year":"2017","unstructured":"Akasaka-Manya K, Kawamura M, Tsumoto H, Saito Y, Tachida Y, Kitazume S, et al. Excess APP O-glycosylation by GalNAc-T6 decreases A\u03b2 production. J Biochem. 2017;161(1):99\u2013111.","journal-title":"J Biochem"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"19235","DOI":"10.1074\/jbc.R116.746032","volume":"291","author":"RJ Andrew","year":"2016","unstructured":"Andrew RJ, Kellett KA, Thinakaran G, Hooper NM. A Greek tragedy: the growing complexity of Alzheimer amyloid precursor protein proteolysis. J Biol Chem. 2016;291:19235\u201344.","journal-title":"J Biol Chem"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fnins.2019.00473","volume":"13","author":"SA Ansari","year":"2019","unstructured":"Ansari SA, Emerald BS. The role of insulin resistance and protein O-GlcNAcylation in neurodegeneration. Front Neurosci. 2019;13:473.","journal-title":"Front Neurosci"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1471-2164-9-328","volume":"9","author":"E Arikawa","year":"2008","unstructured":"Arikawa E, Sun Y, Wang J, Zhou Q, Ning B, Dial SL, et al. Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. BMC Genomics. 2008;9:328.","journal-title":"BMC Genomics"},{"key":"664_CR5","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1073\/pnas.0601279103","volume":"103","author":"A Botella-L\u00f3pez","year":"2006","unstructured":"Botella-L\u00f3pez A, Burgaya F, Gav\u00edn R, Garc\u00eda-Ayll\u00f3n MS, G\u00f3mez-Tortosa E, Pe\u00f1a-Casanova J, et al. Reelin expression and glycosylation patterns are altered in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103:5573\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/0169-328X(93)90095-7","volume":"18","author":"P Buckland","year":"1993","unstructured":"Buckland P, Tidmarsh S, Spurlock G, Kaiser F, Yates M, O'Mahony G, et al. Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer\u2019s and Down\u2019s patients. Brain Res Mol Brain Res. 1993;18:316\u201320.","journal-title":"Brain Res Mol Brain Res"},{"issue":"27","key":"664_CR8","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1073\/pnas.1705235114","volume":"114","author":"V Bustos","year":"2017","unstructured":"Bustos V, Pulina MV, Kelahmetoglu Y, Sinha SC, Gorelick FS, Flajolet M, et al. Bidirectional regulation of A\u03b2 levels by Presenilin 1. Proc Natl Acad Sci U S A. 2017;114(27):7142\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1523\/JNEUROSCI.18-23-09629.1998","volume":"18","author":"JD Buxbaum","year":"1998","unstructured":"Buxbaum JD, Thinakaran G, Koliatsos V, O'Callahan J, Slunt HH, Price DL, et al. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci. 1998;18:9629\u201337.","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"664_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","volume":"120","author":"S Chasseigneaux","year":"2012","unstructured":"Chasseigneaux S, Allinquant B. Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2: similarities and differences. J Neurochem. 2012;120(Suppl 1):99\u2013108.","journal-title":"J Neurochem"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-140096","volume":"44","author":"YS Chun","year":"2015","unstructured":"Chun YS, Park Y, Oh HG, Kim TW, Yang HO, Park MK, et al. O-GlcNAcylation promotes non-Amyloidogenic processing of amyloid-\u03b2 protein precursor via inhibition of endocytosis from the plasma membrane. J Alzheimers Dis. 2015;44:261\u201375.","journal-title":"J Alzheimers Dis"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2017.06.067","volume":"490","author":"YS Chun","year":"2017","unstructured":"Chun YS, Kwon OH, Chung S. O-GlcNAcylation of amyloid-\u03b2 precursor protein at threonine 576 residue regulates trafficking and processing. Biochem Biophys Res Commun. 2017;490:486\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"664_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.410250404","volume":"25","author":"AW Clark","year":"1989","unstructured":"Clark AW, Krekoski CA, Parhad IM, Liston D, Julien JP, Hoar DI. Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol. 1989;25(4):331\u20139.","journal-title":"Ann Neurol"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1073\/pnas.85.4.1227","volume":"85","author":"ML Cohen","year":"1988","unstructured":"Cohen ML, Golde TE, Usiak MF, Younkin LH, Younkin SG. In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. Proc Natl Acad Sci U S A. 1988;85:1227\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-10-2","volume":"10","author":"I Cuchillo-Iba\u00f1ez","year":"2015","unstructured":"Cuchillo-Iba\u00f1ez I, Lopez-Font I, Boix-Amor\u00f3s A, Brinkmalm G, Blennow K, Molinuevo JL, et al. Heteromers of amyloid precursor protein in cerebrospinal fluid. Mol Neurodegener. 2015;10:2.","journal-title":"Mol Neurodegener"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archneur.55.9.1195","volume":"55","author":"M Di Luca","year":"1998","unstructured":"Di Luca M, Pastorino L, Bianchetti A, Perez J, Vignolo LA, Lenzi GL, et al. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol. 1998;55:1195\u2013200.","journal-title":"Arch Neurol"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0896-6273(90)90100-T","volume":"4","author":"TE Golde","year":"1990","unstructured":"Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG. Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer\u2019s disease using PCR. Neuron. 1990;4:253\u201367.","journal-title":"Neuron"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fncel.2018.00435","volume":"12","author":"C Evrard","year":"2018","unstructured":"Evrard C, Kienlen-Campard P, Coevoet M, Opsomer R, Tasiaux B, Melnyk P, et al. Contribution of the endosomal-lysosomal and proteasomal systems in amyloid-\u03b2 precursor protein derived fragments processing. Front Cell Neurosci. 2018;12:435.","journal-title":"Front Cell Neurosci"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3233\/JAD-160160","volume":"53","author":"B Farnsworth","year":"2016","unstructured":"Farnsworth B, Peuckert C, Zimmermann B, Jazin E, Kettunen P, Emilsson LS. Gene expression of quaking in sporadic Alzheimer\u2019s disease patients is both upregulated and related to expression levels of genes involved in amyloid plaque and neurofibrillary tangle formation. J Alzheimers Dis. 2016;53:209\u201319.","journal-title":"J Alzheimers Dis"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3233\/JAD-180833","volume":"67","author":"B Foveau","year":"2019","unstructured":"Foveau B, Correia AS, H\u00e9bert SS, Rainone S, Potvin O, Kergoat MJ, et al. Stem cell-derived neurons as cellular models of sporadic Alzheimer\u2019s disease. J Alzheimers Dis. 2019;67:893\u2013910.","journal-title":"J Alzheimers Dis"},{"key":"664_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005535","volume":"13","author":"A Franks","year":"2017","unstructured":"Franks A, Airoldi E, Slavov N. Post-transcriptional regulation across human tissues. PLoS Comput Biol. 2017;13:e1005535.","journal-title":"PLoS Comput Biol"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0006-291X(89)92154-2","volume":"163","author":"J Ghiso","year":"1989","unstructured":"Ghiso J, Tagliavini F, Timmers WF, Frangione B. Alzheimer\u2019s disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: immunohistochemical and biochemical characterization. Biochem Biophys Res Commun. 1989;163:430\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"664_CR23","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1096\/fj.201600713R","volume":"31","author":"AE Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez AE, Mu\u00f1oz VC, Cavieres VA, Bustamante HA, Cornejo VH, Janu\u00e1rio YC, et al. Autophagosomes cooperate in the degradation of intracellular C-terminal fragments of the amyloid precursor protein via the MVB\/lysosomal pathway. FASEB J. 2017;31(6):2446\u201359.","journal-title":"FASEB J"},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.bbadis.2015.07.017","volume":"1852","author":"C Guerreiro","year":"2015","unstructured":"Guerreiro C, Silva B, Crespo \u00c2C, Marques L, Costa S, Tim\u00f3teo \u00c2, et al. Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients. Biochim Biophys Acta. 2015;1852:2116\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.1102664108","volume":"108","author":"A Halim","year":"2011","unstructured":"Halim A, Brinkmalm G, R\u00fcetschi U, Westman-Brinkmalm A, Portelius E, Zetterberg H, et al. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A. 2011;108:11848\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnagi.2019.00273","volume":"11","author":"H Haytural","year":"2019","unstructured":"Haytural H, Lundgren JL, K\u00f6se TB, Jord\u00e0-Siquier T, Kalcheva M, Seed Ahmed M, et al. Non-specific detection of a major Western blotting band in human brain homogenates by a multitude of amyloid precursor protein antibodies. Front Aging Neurosci. 2019;11:273.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"664_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","volume":"404","author":"KT Jacobsen","year":"2011","unstructured":"Jacobsen KT, Iverfeldt K. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-\u03b2 precursor protein (APP). Biochem Biophys Res Commun. 2011;404(3):882\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"664_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0197-4580(91)90090-7","volume":"12","author":"JS Jacobsen","year":"1991","unstructured":"Jacobsen JS, Blume AJ, Vitek MP. Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer\u2019s disease and normal brain by S1 nuclease protection analysis. Neurobiol Aging. 1991;12(5):585\u201392.","journal-title":"Neurobiol Aging"},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ajmg.b.10067","volume":"118B","author":"S Jiang","year":"2003","unstructured":"Jiang S, Zhang M, Ren D, Tang G, Lin S, Qian Y, et al. Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2003;118B:99\u2013102.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"664_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0014-4886(88)90104-5","volume":"102","author":"SA Johnson","year":"1988","unstructured":"Johnson SA, Pasinetti GM, May PC, Ponte PA, Cordell B, Finch CE. Selective reduction of mRNA for the beta-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains. Exp Neurol. 1988;102(2):264\u20138.","journal-title":"Exp Neurol"},{"issue":"6106","key":"664_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325(6106):733\u20136.","journal-title":"Nature"},{"issue":"10","key":"664_CR32","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","volume":"1861","author":"Y Kizuka","year":"2017","unstructured":"Kizuka Y, Kitazume S, Taniguchi N. N-glycan and Alzheimer\u2019s disease. Biochim Biophys Acta Gen Subj. 2017;1861(10):2447\u201354.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3233\/JAD-190060","volume":"69","author":"OH Kwon","year":"2019","unstructured":"Kwon OH, Cho YY, Kim TW, Chung S. O-GlcNAcylation of amyloid-\u03b2 protein precursor by insulin signaling reduces amyloid-\u03b2 production. J Alzheimers Dis. 2019;69:1195\u2013211.","journal-title":"J Alzheimers Dis"},{"issue":"52","key":"664_CR34","doi-asserted-by":"publisher","first-page":"21304","DOI":"10.1074\/jbc.M117.814202","volume":"292","author":"F Liu","year":"2017","unstructured":"Liu F, Xu K, Xu Z, de Las RM, Wang C, Li X, et al. The small molecule luteolin inhibits N-acetyl-\u03b1-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein. J Biol Chem. 2017;292(52):21304\u201319.","journal-title":"J Biol Chem"},{"issue":"12","key":"664_CR35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2174\/156802611795861004","volume":"11","author":"A Lle\u00f3","year":"2011","unstructured":"Lle\u00f3 A, Saura CA. \u03b3-secretase substrates and their implications for drug development in Alzheimer\u2019s disease. Curr Top Med Chem. 2011;11(12):1513\u201327.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"664_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3233\/JAD-161275","volume":"57","author":"I Lopez-Font","year":"2017","unstructured":"Lopez-Font I, Boix CP, Zetterberg H, Blennow K, S\u00e1ez-Valero J. Alterations in the balance of amyloid-\u03b2 protein precursor species in the cerebrospinal fluid of Alzheimer\u2019s disease patients. J Alzheimers Dis. 2017;57(4):1281\u201391.","journal-title":"J Alzheimers Dis"},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","volume":"1161","author":"T Matsui","year":"2007","unstructured":"Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, et al. Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease. Brain Res. 2007;1161:116\u201323.","journal-title":"Brain Res"},{"issue":"6","key":"664_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000092315","volume":"2","author":"M Men\u00e9ndez-Gonz\u00e1lez","year":"2005","unstructured":"Men\u00e9ndez-Gonz\u00e1lez M, P\u00e9rez-Pinera P, Mart\u00ednez-Rivera M, Calatayud MT, Bl\u00e1zquez MB. APP processing and the APP-KPI domain involvement in the amyloid cascade. Neurodegener Dis. 2005;2(6):277\u201383.","journal-title":"Neurodegener Dis"},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00005072-199405000-00012","volume":"53","author":"SS Mirra","year":"1994","unstructured":"Mirra SS, Gearing M, McKeel DW Jr, Crain BJ, Hughes JP, van Belle G, et al. Interlaboratory comparison neuropathology assessments in Alzheimer\u2019s disease: a study of the Consortium to Establish a Registry of Alzheimer\u2019s Disease (CERAD). J Neuropath Exp Neurol. 1994;53:303\u201315.","journal-title":"J Neuropath Exp Neurol"},{"key":"664_CR40","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1074\/jbc.273.9.5013","volume":"273","author":"RD Moir","year":"1988","unstructured":"Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S, et al. Relative increase in Alzheimer\u2019s disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J Biol Chem. 1988;273:5013\u20139.","journal-title":"J Biol Chem"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1471-4159.2005.03595.x","volume":"96","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Kitazume S, Oka R, Maruyama K, Saido TC, et al. Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. J Neurochem. 2006;96:924\u201333.","journal-title":"J Neurochem"},{"issue":"3","key":"664_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jb\/mvy121","volume":"165","author":"N Nakamura","year":"2019","unstructured":"Nakamura N, Kurosaka A. Mucin-type glycosylation as a regulatory factor of amyloid precursor protein processing. J Biochem. 2019;165(3):205\u20138.","journal-title":"J Biochem"},{"issue":"1","key":"664_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-014-1347-2","volume":"129","author":"HS Nhan","year":"2015","unstructured":"Nhan HS, Chiang K, Koo EH. The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol. 2015;129(1):1\u201319.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"664_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-017-0317-z","volume":"9","author":"A Ochalek","year":"2017","unstructured":"Ochalek A, Mihalik B, Avci HX, Chandrasekaran A, T\u00e9gl\u00e1si A, Bock I, et al. Neurons derived from sporadic Alzheimer\u2019s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimers Res Ther. 2017;9(1):90.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"664_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673\u201384.","journal-title":"Lancet Neurol"},{"issue":"4869","key":"664_CR46","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.2457949","volume":"241","author":"MR Palmert","year":"1988","unstructured":"Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, et al. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer\u2019s disease. Science. 1988;241(4869):1080\u20134.","journal-title":"Science"},{"issue":"2","key":"664_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","volume":"125","author":"M Pera","year":"2013","unstructured":"Pera M, Alcolea D, S\u00e1nchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, et al. Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease. Acta Neuropathol. 2013;125(2):201\u201313.","journal-title":"Acta Neuropathol"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12864-017-3683-9","volume":"18","author":"K Perl","year":"2017","unstructured":"Perl K, Ushakov K, Pozniak Y, Yizhar-Barnea O, Bhonker Y, Shivatzki S, et al. Reduced changes in protein compared to mRNA levels across non-proliferating tissues. BMC Genomics. 2017;18:305.","journal-title":"BMC Genomics"},{"issue":"1","key":"664_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molmed.2013.10.001","volume":"20","author":"R Perneczky","year":"2014","unstructured":"Perneczky R, Alexopoulos P, Kurz A. Soluble amyloid precursor proteins and secretases as Alzheimer\u2019s disease biomarkers. Trends Mol Med. 2014;20(1):8\u201315.","journal-title":"Trends Mol Med"},{"issue":"1","key":"664_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbrainres.2003.08.022","volume":"122","author":"P Preece","year":"2004","unstructured":"Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, et al. Amyloid precursor protein mRNA levels in Alzheimer\u2019s disease brain. Brain Res Mol Brain Res. 2004;122(1):1\u20139.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"664_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jalz.2019.09.002","volume":"16","author":"MV Pulina","year":"2020","unstructured":"Pulina MV, Hopkins M, Haroutunian V, Greengard P, Bustos V. C99 selectively accumulates in vulnerable neurons in Alzheimer\u2019s disease. Alzheimers Dement. 2020;16(2):273\u201382.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"664_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/nbdi.2000.0357","volume":"8","author":"C Russo","year":"2001","unstructured":"Russo C, Salis S, Dolcini V, Venezia V, Song XH, Teller JK, et al. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer\u2019s disease and Down\u2019s syndrome brain. Neurobiol Dis. 2001;8(1):173\u201380.","journal-title":"Neurobiol Dis"},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1021\/acschemneuro.9b00143","volume":"10","author":"P Ryan","year":"2019","unstructured":"Ryan P, Xu M, Davey AK, Danon JJ, Mellick GD, Kassiou M, et al. O-GlcNAc modification protects against protein misfolding and aggregation in neurodegenerative disease. ACS Chem Neurosci. 2019;10:2209\u201321.","journal-title":"ACS Chem Neurosci"},{"issue":"1\u20132","key":"664_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0006-8993(02)04159-8","volume":"965","author":"J S\u00e1ez-Valero","year":"2003","unstructured":"S\u00e1ez-Valero J, Fodero LR, White AR, Barrow CJ, Small DH. Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with beta-amyloid peptides. Brain Res. 2003;965(1\u20132):283\u20136.","journal-title":"Brain Res"},{"issue":"4","key":"664_CR55","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1046\/j.1471-4159.1999.721600.x","volume":"72","author":"J S\u00e1ez-Valero","year":"1999","unstructured":"S\u00e1ez-Valero J, Sberna G, McLean CA, Small DH. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurochem. 1999;72(4):1600\u20138.","journal-title":"J Neurochem"},{"key":"664_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/nbdi.1994.0003","volume":"1","author":"R Sandbrink","year":"1994","unstructured":"Sandbrink R, Masters CL, Beyreuther K. APP gene family: unique age-associated changes in splicing of Alzheimer\u2019s betaA4-amyloid protein precursor. Neurobiol Dis. 1994;1:13\u201324.","journal-title":"Neurobiol Dis"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/febs.12590","volume":"281","author":"S Schedin-Weiss","year":"2014","unstructured":"Schedin-Weiss S, Winblad B, Tjernberg LO. The role of protein glycosylation in Alzheimer disease. FEBS J. 2014;281:46\u201362.","journal-title":"FEBS J"},{"key":"664_CR58","doi-asserted-by":"publisher","unstructured":"Schedin-Weiss S, Gaunitz S, Sui P, Chen Q, Haslam SM, Blennow K, et al. Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment. FEBS J. 2019. https:\/\/doi.org\/10.1111\/febs.15197.","DOI":"10.1111\/febs.15197"},{"issue":"19","key":"664_CR59","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1073\/pnas.85.19.7341","volume":"85","author":"DJ Selkoe","year":"1988","unstructured":"Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988;85(19):7341\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.1996.tb34401.x","volume":"777","author":"DJ Selkoe","year":"1996","unstructured":"Selkoe DJ, Yamazaki T, Citron M, Podlisny MB, Koo EH, Teplow DB, et al. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann N Y Acad Sci. 1996;777:57\u201364.","journal-title":"Ann N Y Acad Sci"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.celrep.2017.05.034","volume":"19","author":"G Siegel","year":"2017","unstructured":"Siegel G, Gerber H, Koch P, Bruestle O, Fraering PC, Rajendran L. The Alzheimer\u2019s disease \u03b3-secretase generates higher 42:40 ratios for \u03b2-amyloid than for p3 peptides. Cell Rep. 2017;19:1967\u201376.","journal-title":"Cell Rep"},{"issue":"6","key":"664_CR62","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1007\/s12035-017-0705-1","volume":"55","author":"A Sogorb-Esteve","year":"2018","unstructured":"Sogorb-Esteve A, Garc\u00eda-Ayll\u00f3n MS, Llansola M, Felipo V, Blennow K, S\u00e1ez-Valero J. Inhibition of \u03b3-secretase leads to an increase in presenilin-1. Mol Neurobiol. 2018;55(6):5047\u201358.","journal-title":"Mol Neurobiol"},{"key":"664_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/2277-9175.127998","volume":"3","author":"M Tajadini","year":"2014","unstructured":"Tajadini M, Panjehpour M, Javanmard SH. Comparison of SYBR Green and TaqMan methods in quantitative real-time polymerase chain reaction analysis of four adenosine receptor subtypes. Adv Biomed Res. 2014;3:85.","journal-title":"Adv Biomed Res"},{"issue":"2","key":"664_CR64","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(88)80273-0","volume":"157","author":"S Tanaka","year":"1988","unstructured":"Tanaka S, Nakamura S, Ueda K, Kameyama M, Shiojiri S, Takahashi Y, et al. Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer\u2019s disease. Biochem Biophys Res Commun. 1988;157(2):472\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"664_CR65","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1021\/acschemneuro.8b00574","volume":"10","author":"PF Tao","year":"2019","unstructured":"Tao PF, Huang HC. Regulation of A\u03b2PP glycosylation modification and roles of glycosylation on A\u03b2PP cleavage in Alzheimer\u2019s disease. ACS Chem Neurosci. 2019;10(5):2115\u201324.","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"664_CR66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/JAD-2011-111337","volume":"29","author":"WG Tharp","year":"2012","unstructured":"Tharp WG, Lee YH, Greene SM, Vincellete E, Beach TG, Pratley RE. Measurement of altered A\u03b2PP isoform expression in frontal cortex of patients with Alzheimer\u2019s disease by absolute quantification real-time PCR. J Alzheimers Dis. 2012;29(2):449\u201357.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"664_CR67","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1074\/jbc.273.11.6277","volume":"273","author":"S Tomita","year":"1998","unstructured":"Tomita S, Kirino Y, Suzuki T. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism. J Biol Chem. 1998;273(11):6277\u201384.","journal-title":"J Biol Chem"},{"key":"664_CR68","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.exger.2013.10.008","volume":"48","author":"A Vignini","year":"2013","unstructured":"Vignini A, Morganti S, Salvolini E, Sartini D, Luzzi S, Fiorini R, et al. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer\u2019s disease and frontotemporal lobar degeneration: a real-time PCR study. Exp Gerontol. 2013;48:1505\u20138.","journal-title":"Exp Gerontol"},{"key":"664_CR69","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","volume":"10","author":"X Wang","year":"2017","unstructured":"Wang X, Zhou X, Li G, Zhang Y, Wu Y, Song W. Modifications and trafficking of APP in the pathogenesis of Alzheimer\u2019s disease. Front Mol Neurosci. 2017;10:294.","journal-title":"Front Mol Neurosci"},{"key":"664_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0092-8674(89)90177-3","volume":"57","author":"A Weidemann","year":"1989","unstructured":"Weidemann A, K\u00f6nig G, Bunke D, Fischer P, Salbaum JM, Masters CL, et al. Identification, biogenesis, and localization of precursors of Alzheimer\u2019s disease A4 amyloid protein. Cell. 1989;57:115\u201326.","journal-title":"Cell"},{"key":"664_CR71","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, et al. \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature. 2015;526:443\u20137.","journal-title":"Nature"},{"issue":"6","key":"664_CR72","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jnr.22618","volume":"89","author":"G Wu","year":"2011","unstructured":"Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ. Decrease in brain soluble amyloid precursor protein \u03b2 (sAPP\u03b2) in Alzheimer\u2019s disease cortex. J Neurosci Res. 2011;89(6):822\u201332.","journal-title":"J Neurosci Res"},{"key":"664_CR73","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1074\/jbc.272.12.7977","volume":"272","author":"W Xia","year":"1997","unstructured":"Xia W, Zhang J, Kholodenko D, Citron M, Podlisny MB, Teplow DB, et al. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem. 1997;272:7977\u201382.","journal-title":"J Biol Chem"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00664-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00664-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:16:51Z","timestamp":1650536211000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00664-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00664-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee at the Miguel Hernandez University (code number# UMH.iNJS.01.18), and it was carried out in accordance with the Helsinki Declaration regarding research on humans. All human samples were collected from national Brain banks: Banco de Tejidos Neurol\u00f3gicos, Fundaci\u00f3n CIEN-Unidad de Investigaci\u00f3n Proyecto Alzheimer (UIPA: Madrid, Spain), and the Biobanco en Red de la Regi\u00f3n de Murcia (Biobanc-Mur, Murcia, Spain), that obtained informed consent from all patients or their relatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u201cNot applicable\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors who contributed to this work agree with the presented findings. The authors are inventors of a patent submitted for the use of sAPP glycoforms as potential AD biomarkers. The authors have no other competing interests to disclose in connection to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}